Skip to main content
Fig. 1 | Molecular Autism

Fig. 1

From: A profile and review of findings from the Early Markers for Autism study: unique contributions from a population-based case–control study in California

Fig. 1

EMA study sampling and overall study design framework. Final analytic samples listed for phases represent the total study populations; numbers in specific genetic and biomarker analyses varied (see Table 4). 1Residence counties included: Orange (phase 1 and 2), Imperial (phase 2), and San Diego (phase 2). 2Controls were originally oversampled 2:1 to cases. CA DDS, California Department of Developmental Services; ASD, autism spectrum disorder; ID, intellectual disability; GP, general population controls; PBB, Project Baby’s Breath

Back to article page

Molecular Autism

ISSN: 2040-2392